Cancer Res Treat.  2017 Oct;49(4):1106-1113. 10.4143/crt.2016.613.

Survival of Cancer Patients in Northeast China: Analysis of Sampled Cancers from Population-Based Cancer Registries

• Li Y
• Yu L
• Na J
• Li S
• Liu L
• Mu H
• Bi X
• An X
• Li X
• Dong W
• Pan G

• KMID: 2394829
• DOI: http://doi.org/10.4143/crt.2016.613

Abstract

PURPOSE
The cancer survival was characterized by following up sampled subgroups of cancer cases from three population-based cancer registries in Northeast China.
MATERIALS AND METHODS
Survival analysis was used to analyze 6,871 patients, who had one of the 21 most common cancers based on sampling from the population-based cancer registries of three cities in Liaoning Province. All patients were diagnosed between 2000 and 2002 and were followed up to the end of 2007 by active and passive methods. The 5-year age standardized relative survival rates (ASRS) were estimated for all cancers combined and each of the 21 individual cancers.
RESULTS
The survival status was traced for 80.8% of 8,506 sampled cancer cases. The 5-year ASRS for all 21 cancers combined was 41.5% (95% confidence interval, 40.3 to 42.7), the highest ASRS was observed for thyroid cancer (85.2%), breast cancer (78.9%), uterine corpus cancer (75.9%), and urinary bladder cancer (70.2%); the lowest 5-year ASRS was noted in pancreatic cancer (8.8%), liver cancer (11.0%), esophageal cancer (18.8), and lung cancer (19.6%). The cancer survival rates in Liaoning cities were similar to those of urban areas in mainland China, but significantly lower than those in Hong Kong, Korea, and Japan.
CONCLUSION
The strikingly poor cancer survival rates in three cities of Liaoning Province and in other places in China highlight the need for urgent investment in cancer prevention, early detection, and standardized and centralized treatment.

Keyword

Neoplasms; Population-based study; Cancer registry; Survival rate; China

MeSH Terms

Breast Neoplasms
China*
Esophageal Neoplasms
Hong Kong
Humans
Investments
Japan
Korea
Liver Neoplasms
Lung Neoplasms
Pancreatic Neoplasms
Registries*
Survival Rate
Thyroid Neoplasms
Urinary Bladder Neoplasms

Reference

References

1. Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X. Report of cancer incidence and mortality in China, 2010. Ann Transl Med. 2014; 2:61.

2. Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, Fan L, Li J, Chavarri-Guerra Y, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol. 2014; 15:489–538.

3. Zhao P, Chen W, Kong L. Cancer incidence and mortality in China 2003-2007. Beijing: Military Medical Science Press;2011.

4. Sankaranarayanan R. Cancer survival in Africa, Asia, the Caribbean and Central America. Introduction. IARC Sci Publ. 2011; (162):1–5.

5. Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, et al. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer. 2015; 136:1921–30.

6. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J, et al. Survival of cancer patients in Europe. The Eurocare Study. IARC Scientific Publications No. 132. Lyon: IARC Press;1995.

7. Sankaranarayanan R, Black RJ, Parkin DM. Cancer survival in developing countries. IARC Scientific Publications No. 145. Lyon: IARC Press;1998.

8. Swaminathan R, Rama R, Shanta V. Lack of active follow-up of cancer patients in Chennai, India: implications for population-based survival estimates. Bull World Health Organ. 2008; 86:509–15.

9. Parkin DM, Hakulinen T. Cancer registration, principles and methods: analysis of survival. IARC Sci Publ. 1991; (95):159–76.

10. Brenner H, Arndt V, Gefeller O, Hakulinen T. An alternative approach to age adjustment of cancer survival rates. Eur J Cancer. 2004; 40:2317–22.

11. Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Pulte D, Mapua C, et al. Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the United States. Br J Cancer. 2009; 100:858–62.

12. Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Brenner H. Cancer survival differences between European countries and an urban population from the Philippines. Eur J Public Health. 2011; 21:221–8.

13. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10. Bethesda, MD: National Cancer Institute;1959.

14. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004; 40:2307–16.

15. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, version 2.0. IARC CancerBase No. 5. Lyon: IARC Press;2004.

16. Law SC, Mang OW. Cancer survival in Hong Kong SAR, China, 1996-2001. IARC Sci Publ. 2011; (162):33–41.

17. Xiang YB, Jin F, Gao YT. Cancer survival in Shanghai, China, 1992-1995. IARC Sci Publ. 2011; (162):55–68.

18. Chen JG, Zhu J, Zhang YH, Lu JH. Cancer survival in Qi Dong, China, 1992-2000. IARC Sci Publ. 2011; (162):45–53.

19. Brenner H, Gefeller O, Hakulinen T. A computer program for period analysis of cancer patient survival. Eur J Cancer. 2002; 38:690–5.

20. Woo ZH, Hong YC, Kim WC, Pu YK. Cancer survival in Incheon, Republic of Korea, 1997-2001. IARC Sci Publ. 2011; (162):163–9.

21. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T, et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol. 2011; 41:40–51.

22. Liu Y, Rao K, Wu J, Gakidou E. China's health system performance. Lancet. 2008; 372:1914–23.

23. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010; 11:165–73.

24. Kwong A, Mang OW, Wong CH, Chau WW, Law SC; Hong Kong Breast Cancer Research Group. Breast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001. Ann Surg Oncol. 2011; 18:3072–8.

25. Cheung FY, Mang OW, Law SC. A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997-2006. Hong Kong Med J. 2011; 17:89–95.

26. Wong KH, Mang OW, Au KH, Law SC. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study. Hong Kong Med J. 2012; 18:466–74.

27. Zhao Y, Dong W, Sun L, Xiao W, Pan T. A sampling investigation on executing the diagnosis and management norm for cancer in Liaoning province. Bull Chin Cancer. 2004; 13:12–4.

28. Li DL, Zheng Y, Chen HQ, Xu YC, Lu W. Evaluation of implement of the diagnosis and treatment criterion for common cancer in China in Shanghai. Bull Chin Cancer. 2001; 10:192–5.